Communiqués Rapid Micro Biosystems, Inc.

Actions

RPID

US75340L1044

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 03/09/2026			Varia. 5j.	Varia. 1 janv.
1,380 ^USD	-0,72%		-14,29%	-52,41%

07/08	Rapid Micro Biosystems, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
07/08	Transcript : Rapid Micro Biosystems, Inc., Q2 2026 Earnings Call, Aug 07, 2026

Communiqués

07/08	Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results	AQ
05/08	Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2026	AQ
04/08	Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
27/07	Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026	AQ
23/07	Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026	AQ
10/06	Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	AQ
19/05	Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering	AQ
13/05	Rapid Micro Biosystems : Corporate Presentation — May 2026	PU
13/05	Rapid Micro Biosystems Reports First Quarter 2026 Financial Results	AQ
06/05	Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026	AQ
08/04	Rapid Micro Biosystems : Corporate Presentation — April 2026	PU
12/03	Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance	AQ
12/03	Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform	AQ
10/03	Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum	AQ
03/03	Rapid Micro Biosystems : TD Cowen 46th Annual Health Care Conference Presentation	PU
26/02	Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference	AQ
24/02	Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026	AQ
12/02	Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
13/01	Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue	AQ
07/01	Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference	AQ
07/11	Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance	AQ
30/10/25	Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference	AQ
28/10/25	Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025	AQ
22/09/25	Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices	PR
02/09/25	Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference	AQ